NCT02125253View on ClinicalTrials.gov

Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

811

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

June 30, 2014

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

Mometasone Furoate Nasal Spray, 50 mcg

a metered-dose, manual pump spray unit containing an aqueous suspension of mometasone furoate

DRUG

Nasonex Nasal Spray, 50 mcg

a metered-dose, manual pump spray unit containing an aqueous suspension of mometasone furoate monohydrate

DRUG

Placebo Nasal Spray

a metered-dose, manual pump spray unit containing an aqueous suspension

Trial Locations (10)

76708

Allergy & Asthma Care of Waco, Waco

78028

Kerrville Research Associates, Kerrville

78130

Central Texas Health Research, New Braunfels

78229

Allergy & Asthma Research Center, San Antonio

Biogenics Research Institute, San Antonio

Diagnostics Research Group, San Antonio

Sylvania Research, San Antonio

78731

Isis Clinical Research, Austin

78750

Austin Clinical Research, Austin

78759

Sirius Clinical Research, Austin

Sponsors
All Listed Sponsors
collaborator

Novum Pharmaceutical Research Services

INDUSTRY

lead

Amneal Pharmaceuticals, LLC

INDUSTRY